Gelsolin could not be considered as a specific marker of lean NAFLD, however, the significantly decreased levels of plasma gelsolin in lean NAFLD patients may suggest secondary inflammation and liver injury. Here, GSN is linked to metabolic dysfunction-associated steatotic liver disease.